Halozyme Therapeutics Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on HALO yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
A German court reportedly overturned an injunction that had been obtained against Merck, a development that weighed on Halozyme shares. The headline gives no further detail on the ruling's scope or what it means for the drugs involved.
Halozyme issued a press release updating investors on a German preliminary injunction hearing involving Merck's subcutaneous Keytruda. The teaser indicates an earlier German decision ordering Merck to stop distributing that product was overturned.
No SEC financials for HALO yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.